![]() |
|
|
Vol. 289, Issue 1, 551-558, April 1999
Neurological and Urological Diseases Research, Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois
| |
Abstract |
|---|
|
|
|---|
ATP-sensitive K+ (KATP) channels play an
important role in the regulation of smooth muscle membrane potential.
To investigate the properties of KATP channels in guinea
pig urinary bladder smooth muscle cells, fluorescence-based assays were
carried out with the membrane potential-sensitive probe
bis-(1,3-dibutylbarbituric acid)trimethine oxonol
[DiBAC4(3)]. The prototypical channel openers, including
pinacidil, (
)-cromakalim, and diazoxide, elicited
concentration-dependent decreases in membrane potential that were
attenuated by glyburide. Similar responses were evoked by a reduction
in intracellular ATP levels by metabolic inhibition. The observed rank
order potency (EC50) for evoking membrane potential changes
by potassium channel openers, P1075 (53 nM) ~ Bay X 9228 > (
)-cromakalim ~ ZD6169 ~ pinacidil > Bay X
9227 ~ ZM244085 > diazoxide (59 µM), showed a good
correlation with that of bladder smooth muscle relaxation, as assessed
by isolated tissue bath studies. The maximal efficacies of
(
)-cromakalim, pinacidil, Bay X 9228, and ZD6169 were
comparable with the response achieved by the reference activator P1075.
Whole cell currents in bladder smooth muscle cells were increased in both inward and outward directions by P1075 and were reversed by
glyburide to control levels. The molecular composition assessed by
reverse transcriptase-polymerase chain reaction analysis using subunit-specific primers revealed the presence of mRNA for inward rectifying potassium channel (KIR6.2) and sulfonylurea
receptors (SUR)2B and SUR1. The subunit profile together with
pharmacological properties suggests that the KATP channel
in bladder smooth muscle cells could be composed of SUR2B associated
with a single inward rectifier, KIR6.2. In summary, these
studies have characterized the pharmacological profile using
fluorescent imaging plate reader-based membrane potential techniques
and provide evidence for the molecular identity of KATP
channels expressed in guinea pig bladder smooth muscle cells.
| |
Introduction |
|---|
|
|
|---|
Potassium
channels of the ATP-sensitive (KATP) family are
inhibited by increases in intracellular ATP and activated by MgADP, thereby coupling cellular excitability and potassium fluxes to cell
metabolism. KATP channels have been described in
diverse cell types, including cardiomyocytes, pancreatic
cells,
neurons, and smooth and skeletal muscle cells, where they play
important physiological and pathophysiological roles (Noma, 1983
;
reviewed in Ashcroft and Ashcroft, 1990
; Isomoto and Kurachi, 1997
;
Quayle et al., 1997
). For example, activation of these channels
protects cardiomyocytes from ischemia and relaxes smooth muscles in the vasculature, bladder, digestive tract, and uterus, whereas channel inhibition triggers events such as insulin secretion and transmitter release. These channels are inhibited by sulfonylurea analogs such as
glyburide and activated by a structurally heterogeneous class of
potassium channel openers (KCOs), including diazoxide, cromakalim, and
pinacidil (Edwards and Weston, 1993
; Gopalakrishnan et al., 1993
).
Pharmacological evidence has suggested a diversity of
KATP channels among various tissues based on
differing sensitivities to KCOs and sulfonylurea inhibitors, an
observation consistent with the results of recent molecular cloning and
heterologous expression studies (Inagaki et al., 1995
, 1996
; Isomoto et
al., 1996
). The KATP channel expressed in
pancreatic
cells is a multimeric complex composed of an inward
rectifying potassium channel, KIR6.2, and a
sulfonylurea receptor (SUR) SUR1, with a stoichiometry of (SUR/KIR6.x)4 (Clement et
al., 1997
; reviewed in Bryan and Aguilar-Bryan, 1997
; Lorenz et al.,
1998
). Recent studies suggest that the site at which ATP interacts to
mediate channel inhibition may reside within the
KIR subunit, whereas the stimulatory effects of
MgADP and KCOs may involve interactions with the SUR subunit (Gribble et al., 1997
; Shyng et al., 1997
; Tucker et al., 1997
; Schwanstecher et
al., 1998
).
In contrast to the well characterized pancreatic channels, the nature
of KATP channels present in other tissues is less
well understood. The sulfonylurea receptor SUR2A has a lower affinity for glyburide than does SUR1 and combines with
KIR6.2 to form channels that are activated by
pinacidil but not diazoxide, properties typical of
KATP channels in cardiac and skeletal muscle
(Inagaki et al., 1996
; Okuyama et al., 1998
). From expression studies
using rat or mouse SUR subunits, it is currently thought that the
molecular composition of the cardiac/skeletal muscle channel is
SUR2A-KIR6.2, whereas SUR2B is thought to be one
of the subunits constituting the smooth muscle-type
KATP channels as inferred from pharmacological properties and tissue distribution. Studies by Kurachi and coworkers have shown that the pharmacology of the SUR2B subunit coexpressed with
KIR6.2 and KIR6.1 resembles
that of smooth muscle KATP channels and smooth
muscle nucleotide diphosphate-dependent channels, respectively (Isomoto
et al., 1996
; Yamada et al., 1997
).
In smooth muscles, including those from the urinary bladder, KCOs
activate KATP channels, leading to membrane
hyperpolarization, reduction in cellular calcium entry, and inhibition
of muscle contractility. Electrophysiological studies have demonstrated the presence of KATP channels in guinea pig
urinary bladder, the modulation of which may regulate bladder
contractility (Bonev and Nelson, 1993
). The recent molecular
identification of the KATP channels has renewed
interest in the development of selective channel openers for the
treatment of smooth muscle dysfunction, including detrusor instability.
Accordingly, the objective of the present study was to characterize the
pharmacology of native KATP channels expressed in
cultured guinea pig bladder smooth muscle cells using
fluorescence-based assays of membrane potential and to relate these to
detrusor relaxation and molecular composition of these channels.
| |
Experimental Procedures |
|---|
|
|
|---|
Cell Culture.
Urinary bladders were removed from
anesthetized male guinea pigs (Hartley, Charles River, Wilmington, MA)
weighing 250 to 300 g and placed in ice-cold
Ca2+-free Krebs' solution (2.7 mM KCl, 1.5 mM
KH2PO4, 75 mM NaCl, 9.6 mM
NaH2PO4, 8 mM
Na2HPO4·7H2O,
2 mM MgSO4, 5 mM glucose, 10 mM HEPES, pH 7.4).
Cells were isolated by enzymatic dissociation as previously described
(Klockner and Isenberg, 1985
) with some modifications. The bladder was
cut into small sections and incubated in 5 ml of the Krebs' solution
containing 1 mg/ml collagenase (type VIII; Sigma Chemical Co., St.
Louis, MO) and 0.2 mg/ml pronase (Calbiochem, La Jolla, CA) with
continuous stirring at 37°C in a cell incubator for 30 min. The
mixture was then centrifuged at 1300g for 5 min, and the
pellet resuspended in Dulbecco's PBS (Life Technologies, Gaithersburg,
MD) and recentrifuged to remove residual enzyme. The cell pellet was
resuspended in 5 ml of growth media (Dulbecco's modified Eagle's
medium supplemented with 10% FBS, 100 units/ml penicillin, 100 units/ml streptomycin, and 0.25 mg/ml amphotericin B) and further
dissociated by pipetting it repeatedly through a flame-polished Pasteur
pipette and passing it through a polypropylene mesh membrane (Spectrum,
Houston, TX). The cell density was adjusted to 100,000 cells/ml by
resuspension in growth media and plated onto clear-bottomed black
96-well plates (Packard ViewPlate-96) for fluorescence studies at a
density of 20,000 cells/well. Cells were maintained in a cell incubator
with 90% air/10% CO2 for 5 to 7 days.
Cell Characterization.
Cells were labeled with smooth
muscle-specific
-actin to determine the population of muscle-type
cells in the preparation. For cytoskeletal staining, cells were removed
from the culture flask after 5 days in culture and plated onto
dual-chambered glass slides for 48 h in growth media. Cells were
washed twice with Dulbecco's PBS, fixed in 70% methanol for 30 min,
and blocked with 0.5% casein and 10% rabbit serum (Sigma Chemical
Co.). The primary antibody was a monoclonal mouse anti-human
-smooth
muscle actin raised against the amino-terminal region (Biomeda, Foster City, CA) ,and the secondary antibody was biotinylated rabbit anti-mouse. Horseradish peroxidase conjugate was used to detect the
bound secondary antibody, and staining was enhanced using 5% copper
sulfate. Positive staining for
-actin was observed in 60 to 70% of
the cells cultured for 5 to 7 days, during which the cells were used
for various studies. Although we have used anti-human
-smooth muscle
actin, the positive staining data indicates cross-reactivity with the
guinea pig protein. The remaining population of cells may include other
cell types, such as those of urothelial origin. No specific staining
was observed when the primary antibody was not included or when
staining was performed under similar conditions using fibroblast lines
such as COS-7.
RNA Preparation and Reverse Transcription-Polymerase Chain
Reaction Analysis (RT-PCR).
For RNA isolation, guinea pig bladder
cells grown in T162-cm2 flasks (1 × 107 cells) were rinsed twice with
Dulbecco's PBS, gently trypsinisized (0.25%
trypsin, 1 mM EDTA; Life Technologies), pelleted by centrifugation, and
stored at
80°C until used. Total RNA from guinea pig bladder smooth
muscle cells was isolated using TRIzol reagent according to the
manufacturer's instructions (Life Technologies). First-strand synthesis of cDNA using random hexamers was prepared as follows: An 1- to 2-µg aliquot of DNase I-treated total RNA isolated from cells or
tissues was incubated with random hexamers at 70°C for 10 min and
then with PCR buffer (20 mM Tris·HCl, pH 8.4, 50 mM KCl), 2.5 mM
MgCl2, 1 mM deoxynucleoside-5'-triphosphate, and 10 mM dithiothreitol at 25°C for 5 min. RT-PCR was initiated by the
addition of Superscript II RT (200 U) at 25°C for 10 min followed by
incubation at 42°C for 50 min. The reaction was terminated by
incubation at 70°C for 15 min, before chilling on ice. PCR was
performed using 2 to 4 µl of cDNA in 50-µl reaction containing 0.4 mM concentration of each primer, 200 mM concentration of each deoxynucleoside-5'-triphosphate, and 2.5 units of Taq
polymerase (Perkin Elmer, Norwalk, CT). The cycling conditions were
95°C for 24 s, 55°C for 22 s, and 72°C for 78 s
for 40 cycles. An aliquot (30 µl) of the RT-PCR product was analyzed
on a 10% Tris-borate-EDTA polyacrylamide gel.
|
Membrane Potential Assay.
Functional activity of
KATP channels were measured by evaluating changes
in membrane potential using the bisoxonol dye
bis-(1,3-dibutylbarbituric acid)trimethine oxonol
[DiBAC4(3); Molecular Probes, Eurgene, OR] in a
96-well cell-based kinetic assay system, fluorescent imaging plate
reader (FLIPR) (Schroeder and Neagle, 1996
; Molecular Devices, Menlo
Park, CA). Confluent cells cultured (typically 5-7 days) in black
clear-bottomed 96-well plates were rinsed twice with 200 µl of assay
buffer (20 mM HEPES, 120 mM NaCl, 2 mM KCl, 2 mM
CaCl2, 1 mM MgCl2, 5 mM
glucose, pH 7.4, at 25°C) containing 5 µM
DiBAC4(3) and incubated with 180 µl of buffer
in a cell incubator for 30 min to ensure dye distribution across the
cell membrane. Assays were carried out at 37°C and were initiated by
the addition of 20 µl of a 10× concentration of the test compound
prepared in the assay buffer containing
DiBAC4(3). Changes in fluorescence were monitored
for 25 min by sampling every 30 s from 96 wells simultaneously at
excitation and emission wavelengths of 488 and 520 nm, respectively.
Responses were corrected for any background changes in fluorescence,
and data were normalized to the response observed with 10 µM P1075
(N-cyano-N"-1,
1-dimethylpropyl)-N"-3-pyridylguanidine) P1075 (fluorescence
units arbitrarily assigned as 100%), a potent activator of smooth
muscle KATP channels (Quast et al., 1993
). Generally, a second addition of 5 µM glyburide was made at the end of
25-min period to examine effects on activator-evoked responses. In
studies in which sensitivities to sulfonylureas were evaluated, both
openers and inhibitors were added simultaneously. In experiments assessing the effect of metabolic inhibitors, cells were incubated with
assay buffer lacking glucose but containing 10 mM
2-deoxy-D-glucose and 0.1 µg/ml oligomycin to deplete
intracellular ATP.
Electrophysiology.
Whole-cell currents from guinea pig
bladder smooth muscle cells were measured using the conventional
tight-seal whole-cell clamp method (Hamill et al., 1981
). Measurements
were carried out within 48 h after cell dissociation, during which
the cells appear elongated and contractile. The intracellular pipette
solution contained 107 mM KCl, 1.2 mM MgCl2, 1 mM
CaCl2, 10 mM EGTA, 5 mM HEPES, and 0.1 mM ATP (pH
7.2 with KOH; total K+ ~140 mM). The bath
solution contained 40 mM KCl, 100 mM NaCl, 2.6 mM
CaCl2, 1.2 mM MgCl2, and 5 mM HEPES (pH 7.4 with NaOH). The microelectrodes had a resistance of 2 to 5 M
. After a tight seal was formed, the membrane was ruptured,
and the capacitance transient was integrated online to estimate cell
capacitance. Uncompensated series resistance was typically 3 to 10 M
. The whole-cell currents were amplified using Axopatch-200B
amplifier (Axon Instruments, Foster City, CA) and low pass filtered at
5 kHz (
3 dB, four-pole Bessel filter) before digitization by Digidata 1200B at a sampling rate of 10 kHz. Data were analyzed using pClamp 6.0 (Axon Instruments).
Radioligand Binding.
[3H]P1075
binding was performed on intact bladder smooth muscle cells grown on
12-well dishes for 5 to 6 days through minor modifications of protocols
previously described (Hoffman et al., 1993
; Quast et al., 1993
).
Briefly, culture medium was aspirated from the wells, and the cells
were washed once with assay buffer (20 mM HEPES, 120 mM NaCl, 2 mM KCl,
2 mM CaCl2, 1 mM MgCl2, 5 mM glucose, pH 7.4 at 25°C). Binding was initiated by adding 0.4 ml
of buffer containing varying concentrations of
[3H]P1075. Unlabeled P1075 (10 µM) was used
to define nonspecific binding. Reactions were terminated after 90 min
of incubation in a cell incubator with 10% CO2
by aspirating the supernatant. Free [3H]P1075
was removed by washing the cell monolayer three times with ice-cold
assay buffer. The cells were harvested with 0.4 ml of 0.1 N NaOH,
neutralized with 0.1 N HCl, and then transferred to scintillation
vials, and radioactivity was assessed by liquid scintillation counting.
Isolated Tissue Relaxation.
Urinary bladders were removed
and immediately placed in Krebs-Ringer bicarbonate solution (120 mM
NaCl, 20 mM NaHCO3, 11 mM dextrose, 4.7 mM KCl,
2.5 mM CaCl2, 1.5 mM MgSO4,
1.2 mM KH2PO4, 0.01 mM
K2EDTA, equilibrated with 5%
CO2/95% O2, pH 7.4 at
37°C). Propranolol (4 µM) was included to block
-adrenoceptors.
The trigonal and dome portions were discarded, and strips 3 to 5 mm wide and 10 mm long were prepared from the remaining tissue by cutting
in a circular fashion. One end of the strip was fixed to a stationary
glass rod, and the other was attached to a Grass FT03 transducer at a
basal preload of 1.0g. This preload proved to be the best
condition for a steady-state baseline and reproducible responses to
field stimulation. Two parallel platinum electrodes were included in
the stationary rod to provide field stimulation (parameters: 0.05 Hz,
0.5 ms at 20 V). Tissues were allowed to equilibrate for at least 60 min before the assay. Cumulative concentration-response curves were
generated for each tissue, and each tissue was exposed to only one test
compound. For evaluation of sulfonylurea sensitivity, tissues were
exposed to glyburide for 30 min before generation of the activator
dose-response curve. Individual tissues were exposed to only one
concentration of the test antagonist.
Materials.
Diazoxide, pinacidil, glyburide, tolbutamide,
glipizide, 2-deoxyglucose, and oligomycin were purchased from RBI
(Natick, MA) or Sigma Chemical Co. (St. Louis, MO). (
)-Cromakalim,
P1075, ZD-6169
(S)-N-(4-benzoylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methyl-propionamide, ZM244085 (9-(3 cyanophenyl)hexahydro-1,8 acridinedione), Bay X 9228 ((+)-N-(2-ethoxyphenyl)-N'-(1,2,3-trimethylpropyl)-2-nitroethene-1, 1-diamine), and Bay X 9227 ((
)-N-(2-ethoxyphenyl)-N'-(1,2,3-trimethylpropyl)-2-nitroethene-1,1-diamine) were synthesized at Abbott Laboratories (Abbott Park, IL).
(+)-Cromakalim was obtained from Dr. D. J. Triggle (Buffalo, NY).
Stock solutions of compounds were prepared in 100% dimethyl sulfoxide
and diluted in buffer before use. DiBAC4(3) was
purchased from Molecular Probes. Black 96-well plates with clear
bottoms were purchased from Packard Instruments (Meriden, CT). All cell
culture products were purchased from Life Technologies (Gaithersburg,
MD). The monoclonal mouse anti-human
-smooth muscle actin was
purchased from Biomeda (Foster City, CA). Biotinylated rabbit
anti-mouse, horseradish peroxidase conjugate, and staining reagents
were from DAKO (Carpinteria, CA). The RNA isolation and Superscript II
cDNA synthesis kits were purchased from Life Technologies. Rat and
human poly(A)+ RNAs were obtained from Clontech
(Palo Alto, CA). Taq polymerase was from Perkin Elmer
(Norwalk, CT). The 10% Tris-borate-EDTA polyacrylamide gels were
purchased from Bio-Rad (Hercules, CA).
Data Analysis. The maximal steady-state levels in fluorescence were normalized to the response evoked by a reference potassium channel activator, P1075 (10 µM). Sigmoid curves were fitted to concentration-response data by nonlinear regression analysis (Prism; GraphPAD, San Diego, CA) to obtain EC50 (or IC50) values as appropriate. Wherever plateau responses were not attained, the EC50 values were estimated. Data are expressed as mean ± S.E.M.
| |
Results |
|---|
|
|
|---|
RNA Analysis.
RT-PCR analysis of total cellular RNA isolated
from urinary bladder cells grown in culture for 5 days showed the
expected fragment sizes for KIR6.2 (316 bp), SUR1
(355 bp), and SUR2B (312 bp) (Fig. 1).
Each of these products was confirmed by DNA sequence analysis. Notably,
the primers that were designed to identify SUR2B would also detect the
presence of SUR2A message based on the genomic structure of the SUR2
gene. If both SUR2A and SUR2B were expressed, two products of 451 and
312 bp, respectively, would have been amplified. However, in this case,
no 451-bp product corresponding to SUR2A was detected, indicating that
the SUR2B variant alone is expressed in guinea pig bladder cells. In
addition, negative controls lacking the reverse transcriptase during
the cDNA synthesis step did not yield products.
|
Membrane Potential Studies.
Functional activities of
KATP channels were measured by evaluating changes
in fluorescence responses using DiBAC4(3), an
anionic potentiometric probe that partitions between cells and
extracellular solution in a membrane potential-dependent manner (Epps
et al., 1994
). With increasing membrane potential (e.g., depolarization by 50 mM K+), the probe further partitions into
the cell, resulting in an increase in fluorescence due to dye
interaction with intracellular lipids and proteins, whereas
hyperpolarization evokes a decrease in fluorescence.
Effects of Metabolic Inhibition.
A notable feature of
KATP channels is their sensitivity to
intracellular levels of ATP (Noma, 1983
). To decrease the cellular ATP
content, bladder smooth muscle cells were treated with metabolic inhibitors 2-deoxy-D-glucose (10 mM) and oligomycin (1 µg/ml), agents that have previously been shown to reduce
intracellular ATP levels by
10-fold (Schmid-Antomarchi et al., 1987
;
Bonev and Nelson, 1993
). The addition of metabolic inhibitors resulted in a significant decrease in the fluorescence response that was attenuated by the addition of 5 µM glyburide (Fig.
2).
|
Effects of KCOs.
The addition of KATP
channel openers, including pinacidil analog P1075, (
)-cromakalim, and
diazoxide, elicited concentration-dependent decreases in fluorescence
responses (Fig. 3). The addition of glyburide (5 µM) or barium (3 mM; data not shown) attenuated the responses evoked by P1075. To further verify the nature of fluorescence changes, experiments were carried out by depolarizing the cells by
increasing extracellular K+ concentration. As
shown in Fig. 4, the P1075 (10 µM)-evoked responses were clearly dependent on the membrane potential
with fluorescence responses diminishing at higher
K+ (>30 mM) concentrations.
|
|
)-cromakalim (101%), pinacidil (81%), Bay X
9228 (87%), and ZD6169 (113%) were comparable with the response of 10 µM P1075 (100%). The responses showed stereoselectivity with the
nitroethene analog Bay X 9228 and the benzopyran (
)-cromakalim ~30-
to 50-fold more potent than their corresponding enantiomers (Fig. 5B).
The rank order potencies (EC50) for the openers
were P1075 (53 nM) ~ Bay X 9228 > (
)-cromakalim ~ ZD6169 ~ pinacidil > Bay X 9227 ~ ZM244085 > (+)-cromakalim = diazoxide (59 µM).
|
Sensitivity to Inhibitors.
The sulfonylurea analogs glyburide
and glipizide inhibited fluorescence changes evoked by the potassium
channel activator P1075. Glyburide inhibited responses evoked by P1075
(3 µM) with an IC50 value of 0.90 ± 0.28 µM (n = 4). Glyburide alone had no significant effect
on baseline fluorescence (data not shown). As shown in Fig.
6, complete inhibition of activator
response was observed with 10 µM glyburide. When a second addition of
glyburide was performed at 25 min as depicted in Fig. 3, the responses
were only partially reversed that may be attributed to the
concentration of glyburide used or alternatively due to the subsequent
sampling duration. Glipizide was ~50-fold weaker than glyburide in
inhibiting P1075-evoked responses (IC50 = 46.8 ± 11.3 µM; n = 3; Fig. 6).
|
Radioligand Binding.
Additional support for the presence of
KATP channels in guinea pig bladder smooth muscle
cells is derived from radioligand binding experiments using
[3H]P1075. Recent studies have shown that this
radioligand binds to the SUR2B subunit of the
KATP channel in the presence of ATP (Schwanstecher et al., 1998
). Consistent with the presence of SUR2B
mRNA and KCO-evoked membrane potential responses, specific and
saturable binding of [3H]P1075 was observed in
intact cells within the radioligand concentration range examined.
Scatchard analysis of the data yielded a
Bmax value of 48 ± 14 fmol/mg
protein and a KD value of 6.4 ± 0.9 nM (n = 4; Fig. 7)
This affinity of [3H]P1075 is comparable with
those values reported previously in intact cells or in cells
transfected with the SUR2B subunit (Quast et al., 1993
; Schwanstecher
et al., 1998
).
|
Whole-Cell Patch-Clamp Measurements.
Direct evidence for the
presence of KATP channels in guinea pig bladder
smooth muscle cells was derived from whole-cell patch-clamp recording
studies. Cells were held at a holding potential of
80 mV, and
recordings were made in the presence of extracellular and intracellular
K+ concentrations of 140 and 60 mM, respectively.
In agreement with previous results (Bonev and Nelson, 1993
), the
application of P1075 (10 µM) increased whole-cell inward currents,
which were significantly inhibited by the addition of 5 µM glyburide
(Fig. 8). The currents reversed at
20
mV, which agrees with equilibrium potential for
K+ ions (data not shown).
|
Tissue Relaxation.
Several KCOs were evaluated for their
effects on field-stimulated contractions of guinea pig detrusor.
Low-frequency stimulation (0.1 Hz, 0.5 ms at 20 V) elicited a stable
contractile response in detrusor strips with a tension response of
155 ± 9.9 cg (n = 52). (
)-Cromakalim, P1075,
pinacidil, diazoxide, ZM244085, ZD6169, and Bay X 9228 all suppressed
field-stimulated twitch responses in a concentration-dependent fashion.
The EC50 values together with the efficacies of
these compounds are summarized in Table
2. P1075 and Bay X 9228 were the most
potent of the compounds examined with EC50 values
of 1.2 × 10
7 and 1.7 × 10
7 M, respectively. Bay X 9227 was ~30-fold
less potent and only ~40% as efficacious compared with its
enantiomer Bay X 9228. Consistent with previous observations (Winquist
et al., 1989
), glyburide inhibited the relaxant effects of the
potassium channel activator pinacidil in an apparently competitive
manner with a pA2 value of 6.94 ± 0.39 (slope = 0.99 ± 0.11; r = 0.88;
n = 8). The rank order potency
(EC50) values of KCOs observed for the relaxation of low-frequency stimulated guinea pig detrusor strips, P1075 ~ Bay X 9228 > (
)-cromakalim ~ ZD6169 ~ pinacidil > (+)-cromakalim
diazoxide, showed an excellent
correlation (r = 0.96) with the potencies to evoke
membrane potential changes (Fig. 9).
|
|
| |
Discussion |
|---|
|
|
|---|
Different types of K+ channels (voltage
gated, calcium-activated, and ATP sensitive) have been shown to
modulate spontaneous electrical and mechanical activity in the detrusor
smooth muscle (Brading et al., 1996
). Although previous
electrophysiological studies have demonstrated the presence of
KATP channels in the detrusor (Bonev and Nelson,
1993
), the pharmacological properties and the molecular composition of
these channels have not been examined in detail. In this study, we
characterized the pharmacology of KATP channels
expressed in cultured guinea pig urinary bladder cells by
fluorescence-based membrane potential techniques. It was found that
KATP channels could be activated by metabolic
inhibition or by diverse KCOs with a rank order potency consistent with
those typical of smooth muscle KATP channels.
Furthermore, the subunit profile together with the observed
pharmacological properties suggest that the KATP
channels expressed in guinea pig bladder cells are likely to be
composed of SUR2B coassociated with a single inward rectifier,
KIR6.2.
FLIPR-Based Membrane Potential Assessment of KATP
Channels.
Previous studies have examined
KATP channels in bladder smooth muscle, by tissue
relaxation subsequent to mild contractile stimulus, by assessing
sulfonylurea-sensitive channel conductance after metabolic inhibition
or after potassium channel activation by KCOs or by the internal
perfusion of ATP-free solutions and by assessing membrane potential
changes by microelectrode techniques or by using potentiometric dyes.
The latter technique, more recently developed in a 96-well microplate
format (FLIPR) using the bisoxonol dye DiBAC4(3),
enables studies on KATP channels in a rapid and high-throughput manner (Schroeder and Neagle, 1996
). Epps et al. (1994)
studied the interaction of this bisoxonol dye with A10 smooth muscle
cells and have shown a significant increase in the fluorescence
intensity in response to the addition of KCl, which increases the
membrane potential and, furthermore, a linear relationship between the
change in fluorescence and change in the cell membrane potential.
Pharmacologic Characteristics of KATP Channels.
The rank order potencies for activation observed in membrane potential
studies are consistent with properties typical of smooth muscle
channels that are activated by cromakalim, pinacidil, and diazoxide.
For example, (
)-cromakalim has been shown to activate KATP currents, to hyperpolarize, and to relax a
wide variety of smooth muscles at concentrations ranging from 1 to 10 µM (Quast and Cook, 1989
; Quayle et al., 1995
). The potency of the
nitroethene Bay X 9228 to evoke membrane potential responses and
relaxation of bladder compares well with those reported previously by
Hoffman et al. (1993)
to relax vascular strips. Bay X 9227, on the
other hand, was
30-fold weaker and less efficacious in both membrane potential and relaxation measurements, although a previous study with
this compound has claimed glyburide-insensitive activity at much lower
concentrations (Hunnicutt et al., 1994
). The 1,4-dihydropyridine ZM244085 has previously been shown, by microelectrode techniques, to
activate KATP channels (Li et al., 1996
). In our
study, this compound evoked glyburide-sensitive responses with
potencies similar to those reported for the relaxation of low
K+-stimulated guinea pig detrusor (4 µM) by Li
et al. (1996)
. ZD6169 is a tertiary carbinol with reported in vivo
bladder selectivity identified as a development compound for the
treatment of urge incontinence (Howe et al., 1995
). The potency value
for activation of membrane potential responses by this compound is
comparable with the concentrations required to relax 15 mM
K+-stimulated guinea pig detrusor strips
(EC50 = 1.6 µM) and to increase whole-cell
glyburide-sensitive K+ currents in detrusor
smooth muscle cells (Grant et al., 1994
).
Molecular Analysis of KATP Channels.
RT-PCR
studies demonstrated the presence of the inward rectifier
KIR6.2 as well as the sulfonylurea receptors SUR1
and SUR2B in cultured bladder smooth muscle cells. Although these
studies have addressed only the expression of mRNA transcripts, it is tempting to speculate that KATP channels in the
bladder may be composed of SUR2B-containing subunits on the basis of
the following observations. Although diazoxide is known to activate
both SUR1- and SUR2B-containing channels with similar potencies
(50-200 µM; Ashcroft and Ashcroft, 1990
), the potency of glyburide
to inhibit activator-evoked responses in bladder smooth muscle cells is
~1000-fold lower than its potency for inhibition of
KATP channels composed of
SUR1-KIR6.2 subunits (IC50 = 1-10 nM; Inagaki et al., 1995
, 1996
). This supports the contention
that the predominant combination that mediates activator interactions
in the bladder smooth muscle cells could be composed of SUR2B and
KIR6.2. Although SUR1 message was detected by PCR
analysis, [3H]glyburide binding to guinea pig
bladder membranes failed to reveal any high-affinity saturable binding
sites within the concentration range examined (0.01-6.0 nM), although
under similar conditions, high-affinity
[3H]glyburide binding (KD ~ 0.1 nM) was detected in RINm5F and brain membranes (data not shown)
consistent with previous reports (Schmid-Antomarchi et al., 1987
;
Gopalakrishnan et al., 1991
). This suggests that either SUR1 protein
may not be expressed at significant levels or if it is expressed at
all, it is barely detectable by the current methods of analyses. A
necessary confirmation of the molecular identity of subunits
constituting functional KATP channels could arise
from the analysis of protein levels by the use of antibodies or by
antisense studies. It should be noted, however, that in the present
study, the cell population used in RT-PCR studies is slightly different
from those used in membrane potential measurements in terms of their
growth conditions (i.e.,
T162-cm2 flasks versus 96-well
plates, respectively). Cells sustained under these different
culture environments would not be expected to exhibit a similar
differentiation pattern, which may alter cell composition (smooth
muscle versus non-smooth muscle cells) and expression of mRNA and/or
surface protein.
)-cromakalim and YM-934 can effectively
relax both normal and hyperreflexic human bladder with similar
potencies, suggesting no appreciable alteration in
KATP channel function under hyperreflexic conditions (Martin et al., 1997| |
Acknowledgments |
|---|
We gratefully acknowledge the efforts of synthetic chemists in
the Neurological and Urological Diseases Research and Discovery Process
Research to prepare (
)-cromakalim, P1075, ZD6169, ZM244085, Bay X
9228, and Bay X 9227.
| |
Footnotes |
|---|
Accepted for publication November 4, 1998.
Received for publication June 4, 1998.
Send reprint requests to: Murali Gopalakrishnan, Ph.D., Neurological and Urological Diseases Research, D-47C, Bldg. AP10LL, Pharmaceutical Products Division, Abbott Laboratories, 100 Abbott Park Rd., Abbott Park, IL 60064-3500. E-mail: murali.gopalakrishnan{at}abbott.com
| |
Abbreviations |
|---|
KCO, potassium channel opener; KATP, ATP-sensitive K+ channel; KIR, inwardly rectifying K+ channel; SUR, sulfonylurea receptor; FLIPR, fluorescent imaging plate reader; RT, reverse transcription; PCR, polymerase chain reaction; DiBAC4(3), bis-(1,3-dibutylbarbituric acid)trimethine oxonol.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. P. Frazier, M.-J. Mathy, S. L. M. Peters, and M. C. Michel Does Cyclic AMP Mediate Rat Urinary Bladder Relaxation by Isoproterenol? J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 260 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tertyshnikova, R. J. Knox, M. J. Plym, G. Thalody, C. Griffin, T. Neelands, D. G. Harden, L. Signor, D. Weaver, R. A. Myers, et al. BL-1249 [(5,6,7,8-Tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: A Putative Potassium Channel Opener with Bladder-Relaxant Properties J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 250 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-E. Andersson and A. J. Wein Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary Incontinence Pharmacol. Rev., December 1, 2004; 56(4): 581 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Davis-Taber, E. J. Molinari, R. J. Altenbach, K. L. Whiteaker, C.-C. Shieh, G. Rotert, S. A. Buckner, J. Malysz, I. Milicic, J. S. McDermott, et al. [125I]A-312110, a Novel High-Affinity 1,4-Dihydropyridine ATP-sensitive K+ Channel Opener: Characterization and Pharmacology of Binding Mol. Pharmacol., July 1, 2003; 64(1): 143 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gopalakrishnan, S. A. Buckner, K. L. Whiteaker, C.-C. Shieh, E. J. Molinari, I. Milicic, A. V. Daza, R. Davis-Taber, V. E. Scott, D. Sellers, et al. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-Dioxide (A-278637): A Novel ATP-Sensitive Potassium Channel Opener Efficacious in Suppressing Urinary Bladder Contractions. I. In Vitro Characterization J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 379 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gomes and P. Soares-da-Silva D2-like receptor-mediated inhibition of Na+-K+-ATPase activity is dependent on the opening of K+ channels Am J Physiol Renal Physiol, July 1, 2002; 283(1): F114 - F123. [Abstract] [Full Text] [PDF] |
||||